Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenchymal stem cell recruitment refers to the multi-step process by which MSCs are attracted to, migrate toward, and engraft within sites of tissue injury or inflammation. This process is governed by a complex interplay of chemokines (such as CXCL12/SDF-1), growth factors (like TGFβ1), and adhesion molecules (including selectins, integrins, and CD44), as well as matrix metalloproteinases that facilitate transmigration. MSC recruitment is essential for the therapeutic effects of stem cell-based tissue regeneration and repair, but is not itself a molecular drug target—rather, it is an outcome modulated by manipulating the signaling environment and receptor expression profiles of MSCs in vivo and in vitro. While no drugs specifically "interact" with this process as a single target, it can be modulated by compounds and growth factors such as TGFβ1, CXCL12, and TNFα. Assessment of recruitment may include evaluating cell surface markers like CXCR4, CD44, and integrins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesenchymal stem cell recruitment.